Congo red and protein aggregation in neurodegenerative diseases.
about
Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assemblyThe amyloid-Congo red interface at atomic resolutionThe prion protein binds thiamineBinding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current statusIdentification of fibrillogenic regions in human triosephosphate isomerase.A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregatesNeuroprotective Effect of Fagopyrum dibotrys Extract against Alzheimer's DiseaseQuantifying prefibrillar amyloids in vitro by using a "thioflavin-like" spectroscopic method.Bacterial macroscopic rope-like fibers with cytopathic and adhesive properties.A small molecule inhibitor of Pot1 binding to telomeric DNA.Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease.Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.Recent advances in prion chemotherapeutics.Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.Biomimetic Remineralization of Carious Lesions by Self-Assembling Peptide.Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes.Amyloidogenic peptides of yeast cell wall glucantransferase Bgl2p as a model for the investigation of its pH-dependent fibril formationAmyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan.Extrinsic fluorescent dyes as tools for protein characterizationStructure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta.Hormesis and medicine.The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.Experimental therapeutics in hereditary neuropathies: the past, the present, and the future.Small-molecule theranostic probes: a promising future in neurodegenerative diseases.Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding ProteinsA review of amyloid staining: methods and artifacts.Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease.Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.Anti-amyloid compounds protect from silica nanoparticle-induced neurotoxicity in the nematode C. elegans.Different amyloid aggregation of smooth muscles titin in vitro.Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.Insights into the Photophysics and Supramolecular Organization of Congo Red in Solution and the Solid State.Fluorescent natural products as probes and tracers in biology.Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregatesTransient small molecule interactions kinetically modulate amyloid β peptide self-assembly.Effects of Congo red on aβ(1-40) fibril formation process and morphology.Quantitative feature extraction reveals the status quo of protein fibrillation in the cell nucleus.Structurally distinct toxicity inhibitors bind at common loci on β-amyloid fibril.Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells.
P2860
Q26852205-26812AFD-3A27-4C15-90A3-5970A61004FDQ27667880-BB244EE9-E9C3-435F-A865-7619B4C22836Q27671805-B15277D4-ACC0-4E34-98B0-9F2D98BF84B7Q28393352-7F7BAF95-77CD-465B-8470-4187743DEF5DQ30384397-CE7D6EEA-C6D6-4A49-98BF-6A30ABBBBDBBQ30423892-E065C908-46F2-4E18-90E6-0B65CF6BCE85Q33634398-B446C8AD-FE35-4BD3-94F5-23BD826E0623Q33647141-D5139FD9-D906-4583-BA74-5CA3381EFB0FQ34186513-5BCA0080-43BE-4F77-A5DD-941D7013540BQ34414940-D89C659E-B7DE-4895-9AFA-BD08679518CBQ34584102-AE9763B3-F369-4923-BDE0-9610EA8627EDQ35168349-ED7B228B-EE51-40DE-8D8F-58EBFEECCA55Q35944199-21772A57-1349-47C5-9C34-A20E10336D34Q36119066-B3A06787-602D-4496-9E4E-2FBFE39AB9A3Q36324148-1D3D8199-2389-479F-BA68-CE1128ABE072Q36647027-1612F7BF-50D3-43CD-97EC-19C0D90D0693Q36719211-FF868399-B5AA-44BA-BD78-E751D55EAD81Q36723364-6F4747E9-F00D-411F-A2C6-13569386CDCDQ36738230-2DA917D7-EAD3-4879-AD5C-C33061B3E641Q37019530-DB663FEC-3CE7-4B53-BE54-BC4B5793EE78Q37142421-F7602AFE-AA4C-4754-9A28-066EABE32B33Q37196566-E8907962-E777-441A-8BE8-78DFD128288FQ37329508-E9CF4CCB-964F-4E83-810F-FB1BCAF0ECE6Q37353880-9DD165E6-5A02-4FF3-9E49-374BEE1B4D4CQ37401787-8EE24768-19E5-4B2F-A64D-0518BA6B86C8Q37739455-E848A997-91AB-4888-9FD4-6F2E1C106261Q38256782-5B2AFDF4-CD2F-4155-9A68-137C8BE6ABE7Q38261844-1432A090-3B65-4E99-B088-D9FDBDB757D7Q38272021-A22B043B-DCF2-40A6-9EB4-B11AF089E2DDQ38456671-48483092-47F9-4055-A3E0-A55E002A5AB6Q38702791-2091D6C7-861E-4FC5-BB97-AA634D73488FQ38765176-EE531DA8-2EE8-44D7-B666-72C6166CC17FQ39089251-F04312B9-ACB4-4646-82CA-E49CA3DB92AFQ39104569-412924DF-4025-4121-9128-1BB1B53385F9Q39222509-B5EDCB77-C222-4C2A-9102-B5319C3A9F27Q39261157-9E93C8DB-1D6F-40B1-B7E7-2913D4D1AD47Q39287470-AF5F954A-F3EB-4DD2-B911-268C263CD727Q39521736-6D57C11B-8E2C-4501-8DC9-670C39A75F24Q39832389-A0258CC5-25BA-440E-9DD2-3C5CED597388Q39885727-BE2DFB4D-A162-4D01-A66B-87B7CA64C9CB
P2860
Congo red and protein aggregation in neurodegenerative diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Congo red and protein aggregation in neurodegenerative diseases.
@ast
Congo red and protein aggregation in neurodegenerative diseases.
@en
type
label
Congo red and protein aggregation in neurodegenerative diseases.
@ast
Congo red and protein aggregation in neurodegenerative diseases.
@en
prefLabel
Congo red and protein aggregation in neurodegenerative diseases.
@ast
Congo red and protein aggregation in neurodegenerative diseases.
@en
P2093
P1476
Congo red and protein aggregation in neurodegenerative diseases.
@en
P2093
Natalija Popovic
Petrea Frid
Sergey V Anisimov
P304
P356
10.1016/J.BRAINRESREV.2006.08.001
P577
2006-09-07T00:00:00Z